Skip to main content
SVBI logo

SVBI — Investor Relations & Filings

Ticker · 1786 ISIN · TW0001786002 TW Manufacturing
Open in API
Filings indexed 1,687 across all filing types
Latest filing 2020-08-06 Interim / Quarterly Rep…
Country TW Taiwan
Listing TW 1786

About SVBI

www.scivision.com.tw

SciVision Biotech Inc. is a specialized developer and manufacturer of advanced medical devices, focusing on the research and production of hyaluronic acid (HA) products. The company leverages its proprietary Crosslinked Hyaluronic Acid Platform (CHAP) technology to create high-performance solutions across multiple medical disciplines. Its core product portfolio includes subcutaneous fillers for facial aesthetics, intra-articular injections for orthopedic joint care, anti-adhesion gels for surgical applications, and vesical instillation solutions for urological treatments. By integrating specialized R&D capabilities with precision manufacturing, SciVision Biotech provides medical-grade HA applications designed to improve patient outcomes in aesthetics and therapeutic recovery. The company is committed to scientific innovation and the expansion of its patented technology to meet diverse clinical needs in the global healthcare market.

Recent filings

Filing Released Lang Actions
109年第2季資產負債表
Interim / Quarterly Report Classification · 95% confidence The document contains a consolidated balance sheet with detailed financial data for multiple periods, including specific asset, liability, and equity line items with amounts and percentages. The data is for the second quarter of the 109th year (likely referring to a fiscal quarter in Taiwan's calendar system). The document length is 3852 characters, which is relatively short but contains substantive financial data rather than just an announcement or a link to a report. The presence of detailed financial statements for a quarter indicates this is an Interim / Quarterly Report rather than a full Annual Report or just an announcement. There is no indication that this is a certification, proxy, or other type of filing. Therefore, the document is best classified as an Interim / Quarterly Report (IR). H1 2020
2020-08-06 Chinese
109年第2季權益變動表
Interim / Quarterly Report Classification · 95% confidence The document contains detailed financial tables showing changes in equity for the first half of the fiscal year 109 (which corresponds to 2020 in the Taiwanese calendar) and the previous year. It includes line items such as common stock, capital surplus, legal surplus reserve, special surplus reserve, undistributed earnings, retained earnings, and total equity attributable to the parent company and non-controlling interests. The presence of comprehensive financial data for a half-year period indicates this is a financial report for an interim period rather than a brief announcement or a certification. The document length is 4046 characters, which is relatively short but contains substantive financial data, so it is not merely an announcement of a report. The content matches the characteristics of an Interim / Quarterly Report (IR) as it covers a period shorter than a full fiscal year with actual financial statements and analysis. Therefore, the correct classification is IR (Interim / Quarterly Report). H1 2020
2020-08-06 Chinese
109年6月背書保證與資金貸與
Regulatory Filings Classification · 95% confidence The document is a financial disclosure from a listed company, 科妍, providing information about fund loans and endorsement guarantees for the current and previous months, with amounts all zero. The content is a regulatory disclosure of financial status related to guarantees and loans, typical of a regulatory filing rather than a full report or announcement. The document is short (601 characters) and contains no financial statements or detailed analysis, so it is not an Annual Report, Interim Report, or Earnings Release. It does not announce a report publication or voting results. It is best classified as a Regulatory Filing (RNS) as it provides compliance-related financial information without fitting other categories.
2020-07-09 Chinese
109年6月營業收入
Fund Information / Factsheet Classification · 90% confidence The document is a summary report of monthly and cumulative net operating revenue figures for a company named 科妍 for the period 民國109年06月 (June 2020). It includes numerical data on revenue changes compared to the previous year and explanatory notes about accounting standards and reporting practices. The document length is very short (762 characters) and contains no detailed financial statements or analysis, only summarized revenue data. It does not present a full annual or interim report, nor is it an announcement of a report publication. It is a brief financial summary report, which fits best under Fund Information / Factsheet (FS) category, as it provides key financial facts in a concise format.
2020-07-09 Chinese
109年06月內部人持股異動(事後)
Director's Dealing Classification · 95% confidence The document consists of detailed tables listing shareholdings and changes in share ownership by company insiders, including directors, managers, and their related parties. It includes data on shares held, increases, decreases, and trust shares. The content is focused on insider share transactions and holdings rather than financial results, management changes, or other corporate events. There is no indication of a full financial report, earnings release, or meeting materials. The document is not a brief announcement but a detailed disclosure of insider shareholdings. This matches the definition of Director's Dealing (DIRS), which covers reports of personal share transactions by company directors and executives (insider trades). The document length is sufficient and the content is consistent with insider shareholding disclosures.
2020-07-07 Chinese
109年06月董事會成員及持股
Director's Dealing Classification · 95% confidence The document is a detailed tabulation of shareholdings and pledged shares by company insiders, including directors, managers, and related parties. It lists current holdings, pledged shares, and relationships, focusing on insider share ownership and pledging status. There is no indication of financial results, earnings, management discussion, or regulatory certifications. The content aligns with insider shareholding disclosures, which typically fall under notifications of director dealings or insider transactions. Given the detailed insider shareholding data and no other report type indicators, the document is best classified as a Director's Dealing report.
2020-07-07 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.